Literature DB >> 10514233

Cardiomyopathy in duchenne, becker, and sarcoglycanopathies: a role for coronary dysfunction?

T Gnecchi-Ruscone1, J Taylor, E Mercuri, G Paternostro, R Pogue, K Bushby, C Sewry, F Muntoni, P G Camici.   

Abstract

Dilated cardiomyopathy is a feature of Duchenne and Becker muscular dystrophies and occasionally of sarcoglycanopathies. Its pathogenesis is unknown. Patients with myotonic dystrophy have an impairment of coronary smooth muscle and this could contribute to their cardiomyopathy. We used positron emission tomography (PET) to study myocardial blood flow and coronary vasodilator reserve at baseline and during hyperemia in 7 Duchenne, 8 Becker, and 5 sarcoglycanopathy patients. The study was normal in all Becker patients. In contrast, baseline myocardial blood flow was increased and coronary vasodilator reserve blunted in Duchenne and sarcoglycanopathy patients despite normal hyperemic myocardial blood flow. The reduction of coronary vasodilator reserve was due to an increased baseline myocardial blood flow. In Duchenne dystrophy, but not in sarcoglycanopathies, correction for cardiac workload normalized the coronary vasodilator reserve. In the latter patients, abnormal baseline myocardial blood flow could be due to vascular smooth muscle dysfunction. Copyright 1999 John Wiley & Sons, Inc.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10514233     DOI: 10.1002/(sici)1097-4598(199911)22:11<1549::aid-mus10>3.0.co;2-a

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  7 in total

1.  Prevention of cardiomyopathy in mouse models lacking the smooth muscle sarcoglycan-sarcospan complex.

Authors:  R D Cohn; M Durbeej; S A Moore; R Coral-Vazquez; S Prouty; K P Campbell
Journal:  J Clin Invest       Date:  2001-01       Impact factor: 14.808

2.  Mutations in the human delta-sarcoglycan gene in familial and sporadic dilated cardiomyopathy.

Authors:  S Tsubata; K R Bowles; M Vatta; C Zintz; J Titus; L Muhonen; N E Bowles; J A Towbin
Journal:  J Clin Invest       Date:  2000-09       Impact factor: 14.808

Review 3.  Alterations in mitochondrial function as a harbinger of cardiomyopathy: lessons from the dystrophic heart.

Authors:  Yan Burelle; Maya Khairallah; Alexis Ascah; Bruce G Allen; Christian F Deschepper; Basil J Petrof; Christine Des Rosiers
Journal:  J Mol Cell Cardiol       Date:  2009-09-18       Impact factor: 5.000

Review 4.  Cardiac involvement in Becker muscular dystrophy.

Authors:  Josef Finsterer; Claudia Stöllberger
Journal:  Can J Cardiol       Date:  2008-10       Impact factor: 5.223

5.  Cardiac expression of a mini-dystrophin that normalizes skeletal muscle force only partially restores heart function in aged Mdx mice.

Authors:  Brian Bostick; Yongping Yue; Chun Long; Nate Marschalk; Deborah M Fine; Jing Chen; Dongsheng Duan
Journal:  Mol Ther       Date:  2008-12-09       Impact factor: 11.454

6.  Myocardial cell damage in Duchenne muscular dystrophy.

Authors:  C Ramaciotti; S T Iannaccone; W A Scott
Journal:  Pediatr Cardiol       Date:  2003 Sep-Oct       Impact factor: 1.655

Review 7.  Limb-girdle muscular dystrophy.

Authors:  Katherine D Mathews; Steven A Moore
Journal:  Curr Neurol Neurosci Rep       Date:  2003-01       Impact factor: 5.081

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.